Maha FDA seizes medicines worth Rs 9.09 lakh from Mumbai children’s hospital over alleged illegal sale

Mumbai: In a major crackdown aimed at safeguarding public health, the Maharashtra Food and Drug Administration (FDA) has seized an allopathic medicine stock worth over Rs 9.09 lakh from a paediatric hospital in Govandi, Mumbai. The hospital was found illegally retailing medicines without a valid drug license through an unqualified receptionist.

Acting on a special enforcement drive, FDA officials inspected the hospital located at Shivajinagar, Govandi East, on Thursday. During the inspection, officials allegedly discovered that the hospital’s director had stocked massive quantities of allopathic medicines across two separate rooms.

According to FDA, these prescription drugs were being sold directly to patients via a receptionist who had only cleared Class 12. Officials said the individual lacked any statutory or technical qualifications required for dispensing pharmaceuticals under the Pharmacy Act.

FDA officials also seized the hospital’s sales bill book

Furthermore, the FDA seized the hospital’s sales bill book and alleged that several statutory details were missing from the bills issued to patients. According to the agency, the bills contained only the patient’s name, date, medicine name and amount charged.

The FDA alleged that the records did not include details such as batch numbers, manufacturing dates, expiry dates, and manufacturers’ names, which are required under applicable regulations.

Officials seized the medicine stock, valued at Rs 9,09,215.28. Officials said legal proceedings are being initiated under the Drugs and Cosmetics Act, 1940.

Speaking on the action, FDA Commissioner Tukaram Mundhe said, “The Food and Drug Administration will not tolerate any compromise regarding patient health. Strict action will be taken against those selling medicines without a valid license, distributing drugs through unqualified personnel, or violating statutory provisions. Citizens must purchase medicines only from licensed pharmacies and ensure they obtain a proper bill containing all statutory details during every purchase.”

Related Posts

Dr Reddy’s delays semaglutide supplies due to API issue

MUMBAI: Dr Reddy’s Laboratories’ plans to capitalize on the early generic semaglutide market have hit a setback after manufacturing issues delayed supplies of the blockbuster diabetes and weight-loss drug, forcing…

India Tightens Rules On Alcohol-Containing Medicines

New rules on alcohol in medicine: The Centre has brought oral medicines containing more than 12% ethyl alcohol and sold in bottles larger than 30 ml under Schedule H1 In…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Dr Reddy’s delays semaglutide supplies due to API issue

Dr Reddy’s delays semaglutide supplies due to API issue

India Tightens Rules On Alcohol-Containing Medicines

India Tightens Rules On Alcohol-Containing Medicines

One more held in spurious plasma racket; police say he supplied 12 boxes

One more held in spurious plasma racket; police say he supplied 12 boxes

Wegovy, Ozempic regain weight as Indian generics fall behind

Wegovy, Ozempic regain weight as Indian generics fall behind

Drug regulator orders fresh safety labels for five common antimicrobials

Drug regulator orders fresh safety labels for five common antimicrobials

Rajasthan recalls labour-inducing drug after quality test failure

Rajasthan recalls labour-inducing drug after quality test failure